Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)

Market Cap	1.82B
Revenue (ttm)	1.22B
Net Income (ttm)	126.26M
Shares Out	56.98M
EPS (ttm)	2.21
PE Ratio	14.44
Forward PE	n/a
Dividend	1.00 (3.14%)
Ex-Dividend Date	Aug 23, 2024

Volume	159,150
Average Volume	163,811
Open	31.70
Previous Close	31.80
Day's Range	31.60 - 32.00
52-Week Range	24.55 - 33.80
Beta	0.16
RSI	55.91
Earnings Date	Aug 11, 2025

About TPEX:4111

Chi Sheng Pharma & Biotech Co., Ltd engages in the manufacturing, processing, sale, and import and export trade of pharmaceuticals, medical products, cosmetics, health foods, and medical equipment in Taiwan and internationally. Its product portfolio includes antibiotics and chemotherapeutic agents; plasma substitutes and amino acid preparations; water nutrients and electrolyte preparations; vitamins; hepatotropic agents; hormones and adrenal cortical steroids; autonomic nerve agents; antihistamines and antipruritics; antipyretics and analgesics...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1962
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4111

Financial Performance

In 2024, TPEX:4111's revenue was 1.17 billion, an increase of 9.86% compared to the previous year's 1.06 billion. Earnings were 110.63 million, an increase of 61.10%.